alphaveSANOFICONR₹4,180.00

Sanofi Consumer Healthcare India Limited

₹ CrorePeersPGHL SANOFI SENORES INNOVACAP MOREPENLAB IOLCP FDC ASTRAZENMcap ₹9,614 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY25 31/12/2024	FY26 31/12/2025	Last 12M 30/06/2026
Returns
Return on Common Equity	66.30	62.53	62.53
Return on Assets	41.97	43.89	43.89
Return on Capital Employed	88.49	71.02	71.02
Return on Invested Capital	—	2,422.35	—
Margins
EBITDA Margin	37.35	35.18	37.16
Operating Margin	36.73	33.85	33.85
Incremental Operating Margin	—	20.27	—
Pretax Margin	34.06	36.46	37.61
Net Income Margin	24.98	27.33	28.01
FCF Margin	59.23	30.71	30.71
Additional
Effective Tax Rate	26.66	25.04	25.53
Dvd Payout Ratio	0.00	52.77	—
Sustainable Growth Rate	66.30	29.53	62.53
Incremental Operating Margin %	20.27	59.38	—

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.